Debut Plus

877.7

-19.29 -2.15%

18 Jul 2026

NSE Listed

Sakar Healthcare Limited (SAKAR)

Volume: 2,11,488Avg Vol 1W: 3,09,227.4Avg Vol 1M: 1,88,389.552W Range:311960
Market Cap₹1,996 Cr
Current Price₹877.7
Previous Close₹896.99
High / Low (52w)₹960 / ₹311
Volume2,11,488
Avg Vol (1W)3,09,227.4
Avg Vol (1M)1,88,389.5
Stock P/E180.84
Book Value₹145.82
Dividend Yield0%
ROE9.4%
ROA6.34%
Revenue (TTM)₹179 Cr
Revenue Growth15.8%
Profit Margin12.11%
Total Debt₹54 Cr
Shares Outstanding2 Cr
Face Value₹10
EPS (TTM)₹13.7
P/B6.15
Debt / Equity0.3
50 DMA₹812.07
200 DMA₹543.03
Day change-2.15%
Price Chart
877.7 147.20% · 1Y
91731713.5L
2025-07-17
2026-07-16

20-day avg volume: 1.9L shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 11% YoY.
  • Stock trades at a high P/E of 181.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹41 Cr₹43 Cr₹43 Cr₹50 Cr₹53 Cr₹58 Cr₹70 Cr₹71 Cr
EBITDA₹6 Cr₹7 Cr₹7 Cr₹10 Cr₹8 Cr₹7 Cr₹13 Cr₹20 Cr
Net Profit₹2 Cr₹5 Cr₹5 Cr₹6 Cr₹5 Cr₹5 Cr₹10 Cr₹11 Cr
EPS
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹85 Cr₹96 Cr₹130 Cr₹138 Cr₹157 Cr₹179 Cr
EBITDA₹14 Cr₹16 Cr₹22 Cr₹23 Cr₹23 Cr₹30 Cr
Net Profit₹10 Cr₹11 Cr₹15 Cr₹13 Cr₹12 Cr₹18 Cr
EPS6.46.879.966.755.637.95
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹115 Cr₹178 Cr₹268 Cr₹336 Cr₹389 Cr₹415 Cr
Total Liabilities₹34 Cr₹79 Cr₹140 Cr₹163 Cr₹126 Cr₹130 Cr
Equity₹81 Cr₹98 Cr₹127 Cr₹173 Cr₹262 Cr₹285 Cr
Total Debt
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹22 Cr₹15 Cr₹36 Cr₹38 Cr₹142 Cr₹36 Cr
Investing₹-22 Cr₹-47 Cr₹-90 Cr₹-74 Cr₹-52 Cr₹-31 Cr
Financing₹3 Cr₹32 Cr₹55 Cr₹41 Cr₹27 Cr₹-3 Cr
Free Cash Flow₹13 Cr₹4 Cr₹36 Cr₹38 Cr₹142 Cr₹36 Cr
Shareholding
Promoter 52.86% Institutions 24.27% Public 22.87%
Efficiency & Working Capital
ROCE8.4%
Interest Coverage3.5
Dividend Payout
Debtor Days63 d
Inventory Days90 d
Payable Days43 d
Cash Conversion Cycle109 d
Working Capital Days153 d
Shareholding Details

As of 2026-03-31

Promoter52.9%
FII12.9%
DII11.3%
Institutions24.3%
Public22.9%
Promoter Pledge0%
No. of Shareholders9,580
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters60.7%54.2%53.2%53.2%53.2%53.2%53.6%53.6%52.9%52.9%52.9%52.9%
FIIs15.7%14%13.8%13.5%13.5%13.4%13.6%13.6%13.4%13.3%13%12.9%
DIIs0%10.8%10.6%10.6%10.6%10.6%10.9%11%11.3%11.4%11.4%11.3%
Public23.5%21%22.5%22.7%22.7%22.8%22%21.8%22.5%22.4%22.7%22.9%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders6,0567,2997,0017,3867,3137,8678,5988,6088,1157,5657,0699,580
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Sanjay S ShahShareholding of Promoter and Promoter Group45%1.00 Cr
Tata Capital Healthcare Fund IiPublic Shareholding10.4%23,09,910
Hbm Healthcare Investments (cayman) LtdPublic Shareholding6.7%15,00,000
Shah AarshShareholding of Promoter and Promoter Group6.3%14,07,500
Cobra India (mauritius) LimitedPublic Shareholding5.9%13,10,313
Ritaben ShahShareholding of Promoter and Promoter Group1.1%2,45,000
Hi-tech Chemicals LimitedPublic Shareholding1.1%2,36,781
Shah AyushiShareholding of Promoter and Promoter Group0.5%1,00,000
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Sanjay S Shah00%2026-03-31
Shah Aarsh00%2026-03-31
Ritaben Shah00%2026-03-31
Shah Ayushi00%2026-03-31
Tata Capital Healthcare Fund Ii00%2026-03-31
Hbm Healthcare Investments (cayman) Ltd00%2026-03-31
Cobra India (mauritius) Limited00%2026-03-31
Hi-tech Chemicals Limited00%2026-03-31
Sanjay S Shah00%2025-12-31
Shah Aarsh00%2025-12-31
Ritaben Shah00%2025-12-31
Shah Ayushi00%2025-12-31
Board of Directors
NameDesignationYear
Sanjay S Shah.Chairman & Managing Director2025
Aarsh S ShahJoint Managing Director2025
Visalakshi ChandramouliNon-Exec & Non-Independent Dir2025
JIGNESH MUKUNDBHAI PARIKHIndependent Non Exe. Director2025
Khyati B. ShahIndependent Non Exe. Director2025
Sunil MaratheWhole Time Director- Technical2025
Megha Kamal SamdaniIndependent Non Exe. Director2025
Reeya KothariIndependent Non Exe. Director2025
Hiral Vinodbhai PatelIndependent Non Exe. Director2025
Bharat SoniCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Manufacturing of Pharmaceutical pro₹0 Cr
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10252222
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000404
2025000303
2025000202
Company Information
Incorporated2004
ChairmanSanjay S Shah.
AuditorJ S Shah & Co
Investor Email[email protected]
🌐 www.sakarhealthcare.com

📍 10/13 Nr MN Desai Petrol Pump, Sarkhej Bavla Highway, Changodar, Gujarat, 382213

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search